GoHealth, Inc.
GOCO
$3.00
-$0.23-7.12%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.56% | 17.46% | 13.18% | 8.74% | 30.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.56% | 17.46% | 13.18% | 8.74% | 30.17% |
| Cost of Revenue | 20.55% | 5.77% | -12.96% | -17.83% | -13.75% |
| Gross Profit | 4.82% | 20.27% | 19.94% | 16.08% | 45.82% |
| SG&A Expenses | 1.01% | 12.34% | 9.39% | 6.12% | 3.00% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.79% | 8.51% | 2.96% | 0.06% | -0.98% |
| Operating Income | 38.95% | 103.93% | 112.19% | 92.44% | 73.37% |
| Income Before Tax | -462.99% | 64.53% | 105.12% | 96.66% | 77.53% |
| Income Tax Expenses | 931.91% | 1,854.38% | 2,608.66% | 1,372.08% | 283.58% |
| Earnings from Continuing Operations | -464.77% | 62.32% | 102.83% | 95.16% | 77.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 381.73% | -66.97% | -102.72% | -95.01% | -78.49% |
| Net Income | -570.94% | 56.25% | 102.97% | 95.37% | 75.97% |
| EBIT | 38.95% | 103.93% | 112.19% | 92.44% | 73.37% |
| EBITDA | 63.99% | 137.65% | 226.37% | 219.72% | 129.38% |
| EPS Basic | -344.03% | 60.17% | 97.01% | 89.80% | 75.88% |
| Normalized Basic EPS | 297.39% | -2,826.70% | -2,006.89% | -3,163.37% | -344.24% |
| EPS Diluted | -355.60% | 44.42% | 82.52% | 75.48% | 75.06% |
| Normalized Diluted EPS | 383.73% | -773.82% | -1,459.52% | -2,337.89% | -199.38% |
| Average Basic Shares Outstanding | 15.61% | 6.90% | 7.04% | 7.43% | 7.89% |
| Average Diluted Shares Outstanding | 17.92% | 34.56% | 35.32% | 36.28% | 20.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -0.39% |